ACHV ACHIEVE LIFE SCIENCE INC revenue, earnings and financials
For the quarter ended June 30, 2026, ACHIEVE LIFE SCIENCE INC reported revenue of n/a, net income of −$74.8M and diluted EPS of −$0.80; for the fiscal year ended December 2025 revenue was n/a.
ACHV annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income n/a, net income −$54.6M (margin n/a), EPS −$1.25
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income n/a, net income −$39.8M (margin n/a), EPS −$1.24
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income n/a, net income −$29.8M (margin n/a), EPS −$1.50
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income n/a, net income −$42.4M (margin n/a), EPS −$4.00
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income n/a, net income −$33.2M (margin n/a), EPS −$4.08
ACHV quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$74.8M, EPS −$0.80
- Quarter ended Mar 31, 2026: revenue n/a, net income −$10.2M, EPS −$0.19
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$14.7M, EPS −$0.23
- Quarter ended Sep 30, 2025: revenue n/a, net income −$14.4M, EPS −$0.28
- Quarter ended Jun 30, 2025: revenue n/a, net income −$12.7M, EPS −$0.37
- Quarter ended Mar 31, 2025: revenue n/a, net income −$12.8M, EPS −$0.37
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$12.4M, EPS −$0.37
- Quarter ended Sep 30, 2024: revenue n/a, net income −$12.5M, EPS −$0.36
- Quarter ended Jun 30, 2024: revenue n/a, net income −$8.46M, EPS −$0.25
- Quarter ended Mar 31, 2024: revenue n/a, net income −$6.49M, EPS −$0.26
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$5.48M, EPS −$0.23
- Quarter ended Sep 30, 2023: revenue n/a, net income −$7.11M, EPS −$0.34
- Quarter ended Jun 30, 2023: revenue n/a, net income −$8.24M, EPS −$0.43
- Quarter ended Mar 31, 2023: revenue n/a, net income −$8.99M, EPS −$0.50
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$11.2M, EPS −$0.77
- Quarter ended Sep 30, 2022: revenue n/a, net income −$13.1M, EPS −$1.35
- Quarter ended Jun 30, 2022: revenue n/a, net income −$10.5M, EPS −$1.08
- Quarter ended Mar 31, 2022: revenue n/a, net income −$7.57M, EPS −$0.80
- Quarter ended Dec 31, 2021: revenue n/a, net income −$7.15M, EPS −$0.76
- Quarter ended Sep 30, 2021: revenue n/a, net income −$6.69M, EPS −$0.71
ACHV cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$49.5M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$29.8M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$24.5M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$37.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$29.4M, share buybacks n/a
ACHV balance sheet
- Jun 30, 2026: cash $48.0M, total assets $190M, total liabilities $205M, shareholders' equity −$14.7M
- Mar 31, 2026: cash $28.1M, total assets $33.1M, total liabilities $22.4M, shareholders' equity $10.7M
- Dec 31, 2025: cash $20.9M, total assets $41.8M, total liabilities $20.3M, shareholders' equity $21.5M
- Sep 30, 2025: cash $31.9M, total assets $52.0M, total liabilities $18.4M, shareholders' equity $33.6M
- Jun 30, 2025: cash $51.9M, total assets $58.9M, total liabilities $17.3M, shareholders' equity $41.7M
- Mar 31, 2025: cash $13.0M, total assets $27.4M, total liabilities $17.1M, shareholders' equity $10.3M
- Dec 31, 2024: cash $12.8M, total assets $38.6M, total liabilities $17.7M, shareholders' equity $20.9M
- Sep 30, 2024: cash $9.54M, total assets $47.9M, total liabilities $16.5M, shareholders' equity $31.4M
Is ACHV profitable?
No. ACHIEVE LIFE SCIENCE INC lost $114M over the last four quarters.
What is ACHV's EPS?
Diluted earnings per share over the last four quarters were −$1.50; −$0.80 in the latest quarter.